Pakistan Unveils Landmark National Genomics Policy to Transform Healthcare

Pakistan’s First National Genomics Policy: A Healthcare Game-Changer

Pakistan has taken a historic step by introducing its first National Genomics Policy, a move hailed by experts as a turning point for the country’s healthcare system. The policy aims to shift the focus from disease treatment to prevention, leveraging genomics, early screening, and precision medicine to reduce the burden of inherited and preventable diseases.

High-Level Consultation

The Ministry of National Health Services, Regulations and Coordination (MNHSR&C), in collaboration with the Health Services Academy (HSA), hosted a Stakeholders’ Consultative Meeting. Leading experts from Aga Khan University, Quaid-i-Azam University, CEMB Lahore, MIT (USA), and other institutions participated, describing the policy as a landmark initiative for Pakistan’s healthcare future.

The Genomic Burden in Pakistan

Statistics presented during the meeting revealed alarming trends:

• 60–70% of marriages in Pakistan are consanguineous, increasing the risk of recessive genetic disorders by up to 18 times.
• Pakistan has over 10 million thalassemia carriers, with 7,000–10,000 new cases annually and 50,000–100,000 patients currently living with the disease.
• Genomic and inherited diseases cost Pakistan Rs. 200–300 billion annually, with projections reaching Rs. 1 trillion per year by 2050 if no action is taken.

Draft Policy Highlights

Prof Dr Shahid Mahmood Baig of HSA presented the draft policy, which includes:

• Establishing a National Public Health Genomics Program.
• Creating genomic surveillance systems for early detection.
• Expanding workforce training in genomics and molecular biology.
• Developing local diagnostic facilities to reduce reliance on imports.
• Launching preventive screening initiatives, especially for thalassemia.

Evidence shows that preventive screening yields a 10–50 times return on investment, while thalassemia prevention programs can reduce affected births by 60–90%.

Expert Consensus

Participants from universities and research centers across Pakistan welcomed the initiative, emphasizing that it could:

• Reduce disease burden significantly.
• Save billions in healthcare costs.
• Strengthen national health security.
• Position Pakistan among countries adopting modern precision healthcare.

Looking Ahead

The National Genomics Policy represents a high-return public health investment. By prioritizing prevention, screening, and precision medicine, Pakistan is laying the foundation for a healthier, more resilient future.

This landmark initiative signals a new era in healthcare, where science and innovation converge to protect lives and strengthen national health security.